Interferon Alpha 2 (IFNa2)

IFNA2A; IFNA2B; IFNA2C; LeIF A; Alpha-2a Interferon; Interferon Alpha 2b; Interferon Alpha A

SPN	P775
HGNC	5423
PubMed	16479007
UniProt	P01563
Wiki	IFNA2

The successful use of intranasal alpha-2-interferon produced by recombinant DNA technology in the prophylaxis of the common cold was reported by Douglas et al. (1986) and Hayden et al. (1986).

Ezekowitz et al. (1992) demonstrated the usefulness of recombinant alpha-interferon (interferon alfa-2a) for inducing regression of life-threatening corticosteroid-resistant hemangiomas in infancy. The hemangiomas treated were those that impair the function of vital structures or cause life-endangering complications such as thrombocytopenic coagulopathy with giant hemangioma.The authors concluded that adjuvant recombinant IFN alfa-2b treatment given before or at the time of enucleation might be a treatment option for patients with uveal melanoma with high-risk factors for developing metastatic disease.

Reference

"Human leukocyte interferon produced by E. coli is biologically active."
Nature 287:411-416(1980) [PubMed] [Europe PMC] [Abstract]

"The structure of eight distinct cloned human leukocyte interferon cDNAs."
Nature 290:20-26(1981) [PubMed] [Europe PMC] [Abstract]

"DNA sequence of a major human leukocyte interferon gene."
Proc. Natl. Acad. Sci. U.S.A. 78:5435-5439(1981) [PubMed] [Europe PMC] [Abstract]

"Cloning of human leukocyte interferon cDNA and a strategy for its production in E. coli."
Rev. Latinoam. Microbiol. 27:141-150(1985) [PubMed] [Europe PMC] [Abstract]

"A defective retroviral vector encoding human interferon alpha 2 can transduce human leukemic cell lines."
Cancer Gene Ther. 5:247-256(1998) [PubMed] [Europe PMC] [Abstract]

"Heterologous expression, immunochemical and computational analysis of recombinant human interferon alpha 2b."
Springerplus 2:264-264(2013) [PubMed] [Europe PMC] [Abstract]

"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]

"At least three human type alpha interferons: structure of alpha 2."
Science 209:1343-1347(1980) [PubMed] [Europe PMC] [Abstract]

"Formation of genes coding for hybrid proteins by recombination between related, cloned genes in E. coli."
Nucleic Acids Res. 11:5661-5669(1983) [PubMed] [Europe PMC] [Abstract]

"A family of structural genes for human lymphoblastoid (leukocyte-type) interferon."
Nature 287:408-411(1980) [PubMed] [Europe PMC] [Abstract]

"Identification of nine interferon-alpha subtypes produced by Sendai virus-induced human peripheral blood leucocytes."
Biochem. J. 329:295-302(1998) [PubMed] [Europe PMC] [Abstract]

"Assignment of the disulphide bonds of leukocyte interferon."
Nature 289:606-607(1981) [PubMed] [Europe PMC] [Abstract]

"Natural human interferon-alpha 2 is O-glycosylated."
Biochem. J. 276:511-518(1991) [PubMed] [Europe PMC] [Abstract]

"Interferon-alpha 2 variants in the human genome."
J. Interferon Cytokine Res. 15:341-349(1995) [PubMed] [Europe PMC] [Abstract]

"A homology model of human interferon alpha-2."
Proteins 17:62-74(1993) [PubMed] [Europe PMC] [Abstract]

"Zinc mediated dimer of human interferon-alpha 2b revealed by X-ray crystallography."
Structure 4:1453-1463(1996) [PubMed] [Europe PMC] [Abstract]

"The three-dimensional high resolution structure of human interferon alpha-2a determined by heteronuclear NMR spectroscopy in solution."
J. Mol. Biol. 274:661-675(1997) [PubMed] [Europe PMC] [Abstract]

"Determination of the human type I interferon receptor binding site on human interferon-alpha2 by cross saturation and an NMR-based model of the complex."
Protein Sci. 15:2656-2668(2006) [PubMed] [Europe PMC] [Abstract]

"Intermolecular interactions in a 44 kDa interferon-receptor complex detected by asymmetric reverse-protonation and two-dimensional NOESY."
Biochemistry 49:5117-5133(2010) [PubMed] [Europe PMC] [Abstract]

"The consensus coding sequences of human breast and colorectal cancers."
Science 314:268-274(2006) [PubMed] [Europe PMC] [Abstract]